Kim Ju Youn, Kim Sung-Hwan, Song In Geol, Kim Yoo Ri, Kim Tae-Seok, Kim Ji-Hoon, Jang Sung-Won, Lee Man Young, Rho Tai-Ho, Oh Yong-Seog
Division of Cardiology, Department of Internal Medicine, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Banpo-daero 222, Seocho-gu, Seoul, 137-701, Republic of Korea.
Division of Cardiology, Department of Internal Medicine, College of Medicine, Incheon St. Mary's Hospital, The Catholic University of Korea, Incheon, Republic of Korea.
J Interv Card Electrophysiol. 2016 Sep;46(3):315-24. doi: 10.1007/s10840-016-0122-9. Epub 2016 Mar 9.
Several approaches were tried to achieve complete pulmonary vein isolation (PVI). The aims of this study were to (1) compare adenosine-induced PV conduction and exit conduction, (2) determine the adequate adenosine dose, and (3) investigate the correlation of dormant conduction and recurrence of atrial fibrillation (AF).
A total of 378 consecutive patients who underwent PVI from June 2012 to April 2015 were prospectively included (the de novo procedure in 318 (84.1 %) and a redo procedure in 60 (15.9 %)). After the exit block was assessed, 20 mg adenosine was injected into the left atrium. If dormant conduction was observed, 12 and 6 mg of adenosine were injected sequentially.
Exit conduction during PV pacing was observed in 34 patients (9 %), and dormant conduction was observed in 92 patients (24.3 %). Among them, 74 (80.4 %, 74/92) demonstrated dormant conduction without exit conduction and 16 (47.1 %, 16/34) showed exit conduction without dormant conduction. The 20-mg dose of adenosine had an additive yield in patients with dormant conduction, compared to that of 12 mg (93 %, 86/92) or 6 mg (80 %, 74/92). There was no significant difference in the recurrence rate regarding dormant conduction. The pattern of prevalence of reconnected origin during the redo procedure was similar to that of dormant conduction during the index procedure.
There was a discrepancy between adenosine-induced PVI and exit block. Therefore, exit block test has additional value to verify latent incomplete PVI in conjunction with adenosine test. Furthermore, high-dose adenosine had an additive yield.
尝试了多种方法来实现完全肺静脉隔离(PVI)。本研究的目的是:(1)比较腺苷诱发的肺静脉传导和出口传导;(2)确定腺苷的合适剂量;(3)研究隐匿性传导与房颤(AF)复发的相关性。
前瞻性纳入2012年6月至2015年4月期间连续接受PVI的378例患者(初次手术318例(84.1%),再次手术60例(15.9%))。在评估出口阻滞之后,将20mg腺苷注入左心房。如果观察到隐匿性传导,则依次注入12mg和6mg腺苷。
34例患者(9%)在肺静脉起搏期间观察到出口传导,92例患者(24.3%)观察到隐匿性传导。其中,74例(80.4%,74/92)表现为隐匿性传导而无出口传导,16例(47.1%,16/34)表现为出口传导而无隐匿性传导。与12mg(93%,86/92)或6mg(80%,74/92)相比,20mg剂量的腺苷对隐匿性传导患者有额外的检出率。隐匿性传导的复发率无显著差异。再次手术期间重新连接起源的发生率模式与初次手术期间隐匿性传导的模式相似。
腺苷诱发的PVI与出口阻滞之间存在差异。因此,出口阻滞试验结合腺苷试验对于验证潜在的不完全PVI具有额外价值。此外,高剂量腺苷有额外的检出率。